Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $5.3 million.

  • International Stem Cell's Liabilities and Shareholders Equity rose 196.91% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 43.19%. This contributed to the annual value of $5.2 million for FY2024, which is 402.6% down from last year.
  • Per International Stem Cell's latest filing, its Liabilities and Shareholders Equity stood at $5.3 million for Q3 2025, which was up 196.91% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Liabilities and Shareholders Equity peaked at $6.0 million during Q1 2021, and registered a low of $4.9 million during Q3 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $5.4 million, with a median of $5.4 million in 2023.
  • In the last 5 years, International Stem Cell's Liabilities and Shareholders Equity plummeted by 1727.85% in 2021 and then skyrocketed by 1188.02% in 2023.
  • Quarter analysis of 5 years shows International Stem Cell's Liabilities and Shareholders Equity stood at $4.9 million in 2021, then increased by 3.82% to $5.1 million in 2022, then grew by 4.97% to $5.4 million in 2023, then fell by 4.03% to $5.2 million in 2024, then increased by 2.11% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $5.5 million for Q2 2025, and $5.6 million during Q1 2025.